【レポートの概要（一部）】
Table of Contents
Chapter 1. Executive Summary
1.1. Antidiabetics– Industry Summary and Critical Success Factors (CSFs)
Chapter 2. Antidiabetics Industry Outlook
2.1. Market Segmentation
2.2. Market size and growth prospects
2.3. Antidiabetics – Market dynamics
2.3.1. Market driver analysis
2.3.1.1 Growing prevalence of diabetes
2.3.1.2 Presence of a strong product pipeline portfolio
2.3.1.3 Growing prevalence of lifestyle induced disorders such as obesity
2.3.2. Market Restraint Analysis
2.3.2.1. High insulin prices
2.4. Key Opportunities Prioritized
2.5. Industry Analysis – Porter’s
2.6. Antidiabetics – PESTEL analysis
2.7. Antidiabetics market – Pipeline overview
Chapter 3. Antidiabetics Product Outlook
3.1. Antidiabetics market share by product, 2013 & 2020
3.2. Insulin
3.2.1. Insulin market share, by product, 2013 & 2020
3.2.2. Rapid acting analog market
3.2.2.1. Rapid acting analog market, 2012 – 2020 (USD Million)
3.2.3. Long acting analog market
3.2.3.1 Long acting analog market, 2012 – 2020 (USD Million)
3.2.4. Premixed analog market
3.2.4.1 Premixed analog market, 2012 – 2020 (USD Million)
3.2.5. Premixed insulin market
3.2.5.1. Premixed insulin market, 2012 – 2020 (USD Million)
3.2.6. Short acting insulin market
3.2.6.1. Short acting insulin market, 2012 – 2020 (USD Million)
3.2.7. Intermediate acting insulin market
3.2.7.1 Intermediate acting insulin market, 2012 – 2020 (USD Million)
3.3. Other antidiabetics
3.4. Alpha glucosidase inhibitors
3.4.1. Alpha glucosidase inhibitors market, 2012 – 2020 (USD Million)
3.5. Biguanides
3.5.1. Biguanides market, 2012 – 2020 (USD Million)
3.6. Sulphonylureas
3.6.1. Sulphonylureas market, 2012 – 2020 (USD Million)
3.7. GLP 1 (Glucagon like peptide) agonists
3.7.1. GLP 1 agonist market, 2012 – 2020 (USD Million)
3.8. DPP – 4 (Dipeptyl peptides) inhibitors
3.8.1. DPP-4 market, 2012 – 2020 (USD Million)
3.9. Meglitinides
3.9.1. Meglitinides market, 2012 – 2020 (USD Million)
3.10. SGLT – 2 (sodium glucose transport proteins) inhibitors
3.10.1. SGLT – 2 inhibitors market, 2012 – 2020 (USD Million)
3.11. Thiazolodinediones
3.11.1. Thiazolodinediones market, 2012 – 2020 (USD Million)
Chapter 4. Antidiabetics Regional Outlook
4.1. Antidiabetics market share, by region, 2013 & 2020
4.2. North America antidiabetics market
4.2.1. North America antidiabetics market, 2012 – 2020 (USD Million)
4.3. Europe antidiabetics market
4.3.1. Europe antidiabetics market, 2012 – 2020 (USD Million)
4.4. Asia Pacific antidiabetics market
4.4.1. Asia Pacific antidiabetics Market, 2012 – 2020 (USD Million)
4.5. RoW antidiabetics market
4.5.1. RoW antidiabetics market, 2012 – 2020 (USD Million)
Chapter 5. Competitive Landscape
5.1 Sanofi Aventis
5.1.1 Company Overview
5.1.2 Financial Performance
5.1.3 Product Benchmarking
5.1.4 Strategic Initiatives
5.2 Takeda Pharmaceuticals
5.2.1 Company Overview
5.2.2 Financial Performance
5.2.3 Product Benchmarking
5.2.4 Strategic Initiatives
5.3 Eli Lilly
5.3.1 Company Overview
5.3.2 Financial Performance
5.3.3 Product Benchmarking
5.3.4 Strategic Initiatives
5.4 Oramed Pharmaceuticals Inc.
5.4.1 Company Overview
5.4.2 Financial Performance
5.4.3 Product Benchmarking
5.4.4 Strategic Initiatives
5.5 Merck & Co. Inc.
5.5.1 Company Overview
5.5.2 Financial Performance
5.5.3 Product Benchmarking
5.5.4 Strategic Initiatives
5.6 Novo Nordisk
5.6.1 Company Overview
5.6.2 Financial Performance
5.6.3 Product Benchmarking
5.6.4 Strategic Initiatives
5.7 Bristol-Myers Squibb
5.7.1 Company Overview
5.7.2 Financial Performance
5.7.3 Product Benchmarking
5.7.4 Strategic Initiatives
5.8 Halozyme Therapeutics
5.8.1 Company Overview
5.8.2 Financial Performance
5.8.3 Product Benchmarking
5.8.4 Strategic Initiatives
5.9 Pfizer
5.9.1 Company Overview
5.9.2 Financial Performance
5.9.3 Product Benchmarking
5.9.4 Strategic Initiatives
Chapter 6. Methodology and Scope
6.1. Research Methodology
6.2. Research Scope & Assumptions
6.3. List of Data Sources
List of Tables
1. Antidiabetics – Industry Summary & Critical Success Factors (CSFs)
2. Global insulin market, by product, 2012 – 2020 (USD Million)
3. Global other antidiabetics market, by product, 2012 – 2020 (USD Million)
4. Global antidiabetics market, by region, 2012 – 2020 (USD Million)
5. Antidiabetics – Key market driver analysis
6. North America diabetes prevalence (national prevalence %), 2013 & 2035
7. Europe diabetes prevalence (national prevalence %), 2013 & 2035
8. Latin America diabetes prevalence (national prevalence %), 2013 & 2035
9. MENA and Africa diabetes prevalence (national prevalence %), 2013 & 2035
10. CIS diabetes prevalence (national prevalence %), 2013 & 2035
11. Asia Pacific diabetes prevalence (national prevalence %), 2013 & 2035
12. Antidiabetics – Key market restraint analysis
13. Antidiabetics market – Pipeline overview
14. Insulin types and brands
15. List of brands of alpha glucosidase for diabetes
16. List of major brands of biguanides for diabetes
17. Brands and generic names of sulphonylureas for diabetes
18. Brands and generic names of GLP-1 for diabetes
19. List of major brands of DPP-4 for diabetes
20. List of major drugs of meglitinides for diabetes
21. List of major drugs of SGLT-2 for diabetes
22. North America insulin market, by product, 2012 – 2020 (USD Million)
23. North America insulin market, by application, 2012 – 2020 (USD Million)
24. North America other antidiabetics market, by product, 2012 – 2020 (USD Million)
25. Europe insulin market, by product, 2012 – 2020 (USD Million)
26. Europe insulin market, by application, 2012 – 2020 (USD Million)
27. Europe other antidiabetics market, by product, 2012 – 2020 (USD Million)
28. Asia Pacific insulin market, by product, 2012 – 2020 (USD Million)
29. Asia Pacific insulin market, by application, 2012 – 2020 (USD Million)
30. Asia pacific other antidiabetics market, by product, 2012 – 2020 (USD Million)
31. RoW insulin market, by product, 2012 – 2020 (USD Million)
32. RoW insulin market, by application, 2012 – 2020 (USD Million)
33. RoW other antidiabetics market, by product, 2012 – 2020 (USD Million)
List of Figures
1. Antidiabetics market segmentation
2. Global antidiabetics market revenue, 2012 – 2020 (USD Million)
3. Antidiabetics: Market dynamics
4. Diabetes prevalence of top 10 countries in 2013 in the age group of 20 to 79 years (million)
5. Current and projected prevalence of diabetes, by geography, 2013 & 2035 (% increase)
6. Key opportunities prioritized
7. Antidiabetics market – Porter’s analysis
8. Antidiabetics market – PESTEL analysis
9. Antidiabetics market share by product, 2013 & 2020
10. Insulin market share by product, 2013 & 2020
11. Rapid acting analog market, 2012 – 2020 (USD Million)
12. Long acting analog market, 2012 – 2020 (USD Million)
13. Premixed analog market, 2012 – 2020 (USD Million)
14. Premixed insulin market, 2012 – 2020 (USD Million)
15. Short acting insulin market, 2012 – 2020 (USD Million)
16. Intermediate acting insulin market, 2012 – 2020 (USD Million)
17. Global alpha glucosidase inhibitors market, 2012 – 2020 (USD Million)
18. Global biguanides market, 2012 – 2020 (USD Million)
19. Global sulphonylureas market, 2012 – 2020 (USD Million)
20. Global GLP 1 agonist market, 2012 – 2020 (USD Million)
21. Global DPP-4 market, 2012 – 2020 (USD Million)
22. Global meglitinides market, 2012 – 2020 (USD Million)
23. Global SGLT – 2 inhibitors market, 2012 – 2020 (USD Million)
24. Global thiazolodinediones market, 2012 – 2020 (USD Million)
25. Antidiabetics market share by region, 2013 & 2020
26. North America antidiabetics market, 2012 – 2020 (USD Million)
27. Europe antidiabetics market, 2012 – 2020 (USD Million)
28. Asia Pacific antidiabetics market, 2012 – 2020 (USD Million)
29. RoW antidiabetics market, 2012 – 2020 (USD Million)
【レポート販売概要】
■ タイトル：抗糖尿病薬の世界市場分析：製品別（インスリン、ビグアニド、チアゾロジンジオン、GLP-アゴニスト、スルホニル尿素、DPP-4阻害剤、SGLT-2、アルファ – グルコシダーゼ阻害剤、メグリチニド）、セグメント予測 -2020■ 英文：Antidiabetics Market Analysis By Product (Insulin, Biguanides, Thiazolodinediones, GLP-agonists, Sulphonylureas, DPP-4 inhibitors, SGLT-2, Alpha-glucosidase Inhibitors, Meglitinides) And Segment Forecasts To 2020
■ 発行日：2015年1月1日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707051
■ 調査対象地域：グローバル
- Ultra Petroleum Corp.：石油・ガスバリューチェーン分析レポート2013Ultra Petroleum Corp. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Ultra Petroleum Corp." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Ultra Petroleum Corp.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report e …
- 皮膚がん治療ワクチンの世界市場及びパイプラインインサイトSkin cancer incidences are increasing at alarming rates across the world causing high morbidity and mortality. Research and development in field is expected to change the present scenario by providing better therapeutic options for patients. Skin cancer therapeutics available in market used for first-line treatment have modest efficacy which lays emphasis on the development of better products like …
- Lundin Petroleum AB：石油・ガスの開発・生産動向及びコスト分析– Q3, 2012Lundin Petroleum AB Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2012 Summary Lundin Petroleum AB Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for …
- Zontivity（ACS/急性冠症候群）：医薬品市場予測及び分析（～2023）Zontivity (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Zontivity (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023”. The current ACS market - primarily comprised of antithrombotics, antihypertensives, and statins - is flush with well-established standard-of-care therapies, many of which …
- 世界のセイボリースナック市場のニュース及びイベント動向（2014年7月）Synopsis The report provides a review of the latest news and key events in the global savory snacks market during July 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global savory snacks market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in the g …
- 医療料金アウトソーシングの世界市場2015-2019About Global Medical Billing Outsourcing Globally, healthcare spending is expected to increase, which will put additional pressure on healthcare delivery systems, governments, and insurers. The major reasons for increased spending in developed countries are an aging population and lower fertility rate; in emerging countries, it is the lack of infrastructure, increase in chronic diseases, and inequ …
- 企業エンドポイント・サイバーセキュリティの世界市場2015-2020This new report offers comprehensive analysis of enterprise endpoint cyber security solutions and related companies. Visiongain assesses that the enterprise endpoint cyber security market will reach $4.98bn in 2015. Visiongain’s report will ensure that you keep informed and ahead of your competitors. Gain that competitive advantage. The report will answer questions such as: • How is the Enterprise …
- 世界のホームオートメーション及び制御市場：照明制御、セキュリティ制御、HVAC制御などOff late, the home automation and controls have not only led to power savings but have also enhanced the living standards, in turn, offering a convenient life. This report, based on the extensive research study on home automation & controls market, is aimed at identifying the entire market of home automation & controls; specifically, lighting control, security control, access control, HVAC control …
- ビブリオ検査の世界市場2015The report presents a detailed analysis of the Vibrio diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Vibrio definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals - Co …
- Ewing Sarcoma：グローバル臨床試験レビューH2, 2013Ewing Sarcoma Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Ewing Sarcoma Global Clinical Trials Review, H2, 2013" provides data on the Ewing Sarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ewing Sarcoma. It includes an overview of the trial numbers and their recruitment status as per the …
- プロフェッショナルデンタルケアの世界市場予測（～2021年）The global professional dental care market is valued at USD 769.3 million in 2016 and is estimated to reach USD 961.0 million by 2021, with a CAGR of 4.5% during the forecast period of 2016-2021. The growth of this market is mainly attributed to the growing number of small/private dental clinics, rising incidences of dental caries, increasing disposable incomes in emerging countries, growing aware …
- ウェットスーツの世界市場2015-2019About Wetsuits Water sports require waterproof apparel with properties such as thermal padding and breathability. Wetsuits are worn by surfers, divers, windsurfers, triathletes, and individuals engaged in other water sports. It is manufactured using foamed neoprene, which provides thermal insulation, buoyancy, and abrasion resistance. The insulation properties of wetsuits is dependent on the bubbl …
- 超小型衛星の世界市場予測MarketsandMarkets forecast the nanosatellite and microsatellite market size to grow from USD 889.8 Million in 2015 to USD 2.52 Billion by 2020, at a compound annual growth rate (CAGR) of 23.2% from 2015 to 2020. Space industry has been witnessing a rapid advancement in the miniaturization of space technology from the past few years and thus present extensive opportunities for space explorations an …
- 円形細胞脂肪肉腫(Round Cell Liposarcoma)：世界の治験レビュー（2015年上半期版）Round Cell Liposarcoma Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Round Cell Liposarcoma Global Clinical Trials Review, H1, 2015" provides data on the Round Cell Liposarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Round Cell Liposarcoma. It includes an overview of the trial numbers and …
- 世界の電池用材料市場：陰極、陽極、電解質、セパレーター、バインダーThe report focuses on battery materials for lithium battery. It includes cathode, anode, electrolyte, separator, binders, and packaging materials. It further divides the market on the basis of types, applications, and geography. The major material types within this market are cathode, anode, separator, and electrolyte. The market data for these material types is given with respect to volume (tons) …
